Literature DB >> 10069553

Effects of menstrual cycle and female sex steroids on ethanol pharmacokinetics.

M S Mumenthaler1, J L Taylor, R O'Hara, H U Fisch, J A Yesavage.   

Abstract

This study investigated the influence of menstrual cycle and female sex steroid levels on ethanol pharmacokinetics. In a within-subjects design, 24 female volunteers each consumed 0.67 g x kg(-1) ethanol during the menstrual and luteal phases of their menstrual cycle. On each test day, we collected blood samples before ethanol administration to determine estradiol (E2) and progesterone (P) levels and to confirm ovulation. We took 20 or more postdrink breath ethanol concentration readings and examined pharmacokinetic differences between the two phases, using classical pharmacokinetic measures, as well as Michaelis-Menten measures. Despite highly significant differences in measured E2 as well as P levels on the 2 test days, and despite excluding subjects with anovulatory cycles from the analysis, there were no significant differences between menstrual and luteal phases for any of the pharmacokinetic variables. We found no correlation between E2 or P levels and any of the pharmacokinetic measures. In summary, we found no evidence that the tested menstrual cycle phases or varying E2 and progesterone levels significantly influence ethanol pharmacokinetics. Because previous studies about the topic have used few subjects and revealed controversial results, we consider our negative findings based on 24 subjects meaningful.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069553

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  9 in total

1.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

2.  Sleeve gastrectomy surgery: when 2 alcoholic drinks are converted to 4.

Authors:  María Belén Acevedo; J Christopher Eagon; Bruce D Bartholow; Samuel Klein; Kathleen K Bucholz; Marta Yanina Pepino
Journal:  Surg Obes Relat Dis       Date:  2017-11-10       Impact factor: 4.734

3.  Pharmacodynamic effects of intravenous alcohol on hepatic and gonadal hormones: influence of age and sex.

Authors:  Vatsalya Vatsalya; Julnar E Issa; Daniel W Hommer; Vijay A Ramchandani
Journal:  Alcohol Clin Exp Res       Date:  2011-07-28       Impact factor: 3.455

4.  Lactational state modifies alcohol pharmacokinetics in women.

Authors:  Marta Yanina Pepino; Allison L Steinmeyer; Julie A Mennella
Journal:  Alcohol Clin Exp Res       Date:  2007-04-13       Impact factor: 3.455

5.  Chronic ethanol drinking increases during the luteal menstrual cycle phase in rhesus monkeys: implication of progesterone and related neurosteroids.

Authors:  Brandy L Dozier; Cara A Stull; Erich J Baker; Matthew M Ford; Jeremiah P Jensen; Deborah A Finn; Kathleen A Grant
Journal:  Psychopharmacology (Berl)       Date:  2019-01-15       Impact factor: 4.530

6.  Effects of breast pumping on the pharmacokinetics and pharmacodynamics of ethanol during lactation.

Authors:  M Y Pepino; J A Mennella
Journal:  Clin Pharmacol Ther       Date:  2008-07-02       Impact factor: 6.875

7.  Effects of moderate sleep deprivation and low-dose alcohol on driving simulator performance and perception in young men.

Authors:  A Vakulin; S D Baulk; P G Catcheside; R Anderson; C J van den Heuvel; S Banks; R D McEvoy
Journal:  Sleep       Date:  2007-10       Impact factor: 5.849

8.  Biphasic effects of moderate drinking on prolactin during lactation.

Authors:  Julie A Mennella; Marta Yanina Pepino
Journal:  Alcohol Clin Exp Res       Date:  2008-08-18       Impact factor: 3.455

Review 9.  Gender differences in moderate drinking effects.

Authors:  M S Mumenthaler; J L Taylor; R O'Hara; J A Yesavage
Journal:  Alcohol Res Health       Date:  1999
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.